Celcuity Quote - CELC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

13.62

Bid

11.85

Ask

18.50

Volume

105,852

13.09 Day's Range 13.775

11.51 52 Week Range 22.188

Market Cap

505.705M

Previous Close

13.13

Open

13.2173

Last Trade

14.05

Last Trade Time

Financial Volume

US$ 1,435,306

VWAP

13.5596

Average Volume (3m)

253,619

Shares Outstanding

37,129,556

Dividend Yield

PE Ratio

-7.94

Earnings Per Share (EPS)

-1.72

Revenue

Net Profit

-63.78M

Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.celcuity.com

Headquarters

Wilmington, Delaware, USA

Founded

Celcuity Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CELC. The last closing price for Celcuity was US$13.13. Over the last year, Celcuity shares have traded in a share price range of US$ 11.51 to US$ 22.188.

Celcuity currently has 37,129,556 shares outstanding. The market capitalization of Celcuity is US$487.51 million. Celcuity has a price to earnings ratio (PE ratio) of -7.94.

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

Median overall survival (OS) among patients with HR+, HER2- advanced breast cancer who were treatment-naïve in the advanced setting was 77.3 months Median OS among patients previously treated...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.65	5.01156515035	12.97	13.91	12.53	212308	13.33366602	CS
4	0.95	7.49802683504	12.67	13.91	11.64	300402	12.62917925	CS
12	-0.87	-6.00414078675	14.49	16.5431	11.51	253619	13.66162001	CS
26	-2.54	-15.7178217822	16.16	19.77	11.51	305710	15.45270711	CS
52	-1.16	-7.84844384303	14.78	22.188	11.51	278889	15.93404866	CS
156	0.47	3.57414448669	13.15	22.188	4.81	137901	14.09791416	CS
260	1.64	13.6894824708	11.98	33.01	4.03	114713	16.1079498	CS

CELC - Frequently Asked Questions (FAQ)

What is the current Celcuity share price?

The current share price of Celcuity is US$ 13.62

How many Celcuity shares are in issue?

Celcuity has 37,129,556 shares in issue

What is the market cap of Celcuity?

The market capitalisation of Celcuity is USD 487.51M

What is the 1 year trading range for Celcuity share price?

Celcuity has traded in the range of US$ 11.51 to US$ 22.188 during the past year

What is the PE ratio of Celcuity?

The price to earnings ratio of Celcuity is -7.94

What is the reporting currency for Celcuity?

Celcuity reports financial results in USD

What is the latest annual profit for Celcuity?

The latest annual profit of Celcuity is USD -63.78M

What is the registered address of Celcuity?

The registered address for Celcuity is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Celcuity website address?

The website address for Celcuity is www.celcuity.com

Which industry sector does Celcuity operate in?

Celcuity operates in the MEDICAL LABORATORIES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	260.93M
NITON2OFF Inc	US$ 2.6306 (145.85%)	358.28M
CRNCCerence Inc	US$ 19.33 (143.76%)	161.8M
KITTNauticus Robotics Inc	US$ 3.8249 (140.56%)	104.8M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.64M
HWHHWH International Inc	US$ 0.4621 (-28.80%)	7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF	US$ 5.69 (-26.30%)	24.77M
RAINRain Enhancement Technologies Holdco Inc	US$ 5.59 (-23.42%)	161.15k
PTLEPTL Ltd	US$ 9.35 (-23.30%)	1.04M
NXUNXU Inc	US$ 0.725868 (-22.78%)	7.59M
NITON2OFF Inc	US$ 2.6306 (145.85%)	350.92M
TGLTreasure Global Inc	US$ 0.382 (101.58%)	330.82M
ACONAclarion Inc	US$ 0.2984 (110.14%)	305.59M
FCUVFocus Universal Inc	US$ 0.9499 (174.93%)	259.78M
NVDANVIDIA Corporation	US$ 144.47 (4.45%)	222.72M